ANDREA SEBO: Open Payments
NPI 1235900440 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,625 in 125 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $781 · 2025 $2,625
Food & beverage: $2,527Education: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $520 |
| GENZYME CORPORATION | 12 | $234 |
| Novartis Pharmaceuticals Corporation | 11 | $232 |
| ABBVIE INC. | 12 | $183 |
| Genentech USA, Inc. | 9 | $175 |
| Regeneron Healthcare Solutions, Inc. | 10 | $170 |
| PFIZER INC. | 7 | $139 |
| Amgen Inc. | 15 | $136 |
| GlaxoSmithKline, LLC. | 5 | $129 |
| CSL Behring | 4 | $128 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, Xolair, FASENRA, NEFFY, NURTEC ODT, RINVOQ.
Industry payments across MD — which companies pay providers there.
